Health ❯ Healthcare ❯ Research and Development

Clinical Trials

Innovative Therapies Alzheimer's Treatments Vaccine Development Preclinical Testing Therapeutic Innovations Interdisciplinary Collaboration in Medicine Preclinical Studies Emerging Treatments Neurology Alzheimer's Treatment Research Antibody-based Medicines Hormonal Treatments Dementia Research Diagnostic Accuracy Model Validation Teplizumab Efficacy Obesity Treatment Collaborative Medical Research Biomarker Studies Povorcitinib Diagnostic Tests Transplantation Studies New Medications Immunotherapy Combinations Robotic Technology Cancer Vaccines Therapeutics Alzheimer's Disease Treatments Exosome Research Next-Generation Therapies Randomized Controlled Trials Drug Efficacy and Safety Therapeutic Approaches Motor Neurone Disease Research Autoimmune Diseases Diabetes Research Prototyping HPV Self-Collection Pilot Program Diabetes Treatment Innovations Psychiatric Disorders AI in Medicine Lenacapavir Study AI in Clinical Decision-Making Alzheimer's Disease Research

UVM Wins Up to $38 Million to Build AI Digital Twins for ICU Patients

The grant backs a milestone‑gated program to develop and computationally validate patient‑specific immune models before any clinical trials.

FDA Expands Mounjaro Label to Include Cardiovascular Risk Reduction

Silo Pharma Raises $4 Million in Private Placement as Shares Fall 28%

LEO Pharma to Acquire Replay in $50 Million Gene-Therapy Deal

Eli Lilly’s Tirzepatide Surge Collides With Rich-Valuation Concerns

Driehaus and Deerfield Lift Praxis Stakes in Q4, SEC Filings Show

Moderna Secures $1.5 Billion Loan, Outlines Path to 2028 Breakeven

Intranasal Antibody Cuts Mugwort Allergy in Mice, Paving Way for Human Trials

UC Irvine’s Iris Valve Achieves Key Preclinical Milestones